Accurately assessing pain.

Pain often goes unrecognised and under-treated in people with communication difficulties such as dementia. Historically, pain assessment has been subjective, manually based and subsequently under-used by carers. PainChek® is a secure smartphone based medical device, using artificial intelligence to assess and score pain levels. This has transformed pain management.

PainChek® – how it works.

PainChek® is fast and easy to use. The smartphone camera records a short video of the person’s face then analyses the images using facial recognition analytics. It automatically recognises and records facial muscle movements that indicate levels of pain.

The caregiver then uses PainChek® to observe and record pain related behaviours such as movement and how pain is vocalised by the person. Finally, PainChek® calculates an overall pain score and stores the result. This allows the caregiver to monitor the effect of medication and treatment over time.

PainChek® is a world-first pain assessment medical device – with regulatory clearance in Australia and Europe.

Large and growing market in Dementia care:

  • Dementia is a syndrome in which there is deterioration in memory, thinking, behaviour and the ability to perform everyday activities.
  • Worldwide, 50 million people live with dementia, with 10 million new cases every year – with an expected increase to 82 million in 2030 and 152 million in 2050.

The US stats illustrate the increasing prevalence of dementia with advanced age:

  • 5% of those age 71-79.
  • 24% of those age 80-89.
  • 37% for those age 90 and over (Plassman et al, 2007).

Huge psychological and financial impact:

  • Dementia is overwhelming – physically and psychologically – not only for those who have it, but also for their caregivers and families.
  • The high cost of the disease will challenge health systems worldwide.

A need for caregivers:

  • Dementia is one of the major causes of dependency among older people.
  • There are an estimated 150 million Carers for people with dementia and growing.

Australian Federal Government funded for 12 months.

A fully funded, 12 month PainChek® license is now available for all Australian Residential Aged Care facilities. Limited time only!